Endonucleases Market Size, Share & Industry Analysis, By Type (Specific Endonucleases {Restriction Enzymes, CRISPR-Cas Nucleases, and Others} and Non-specific Endonucleases {DNases, RNases, and Others}), By Application (Genomics & Genetic Engineering, Drug Discovery & Research, Molecular Biology, and Others), By Source (Prokaryotic, Eukaryotic, and Others), By End User (Pharmaceutical and Biotechnology Companies, Academic & Research Institutes, and Others), and Regional Forecast, 2026-2034

Last Updated: June 22, 2026 | Format: PDF | Report ID: FBI113905

Buy Now

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Technological Advancements in DNA Modification Techniques
2. Technological Advancements in Genetic Engineering
3. New Product Launches, By Key Players
4. Key Industry Developments Such as Mergers, Acquisitions, and Collaborations
5. Overview: Key Start-ups in CRISPR-based Therapeutics
Global Endonucleases Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Specific Endonucleases
    1. Restriction enzymes
    2. CRISPR-Cas nucleases
    3. Others
  2. Non-specific Endonucleases
    1. DNases
    2. RNases
    3. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Genomics & Genetic Engineering
  2. Drug Discovery & Research
  3. Molecular Biology
  4. Others
3. Market Analysis, Insights and Forecast – By Source
  1. Prokaryotic
  2. Eukaryotic
  3. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical and Biotechnology Companies
  2. Academic & Research Institutes
  3. Others
5. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Endonucleases Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Specific Endonucleases
    1. Restriction enzymes
    2. CRISPR-Cas nucleases
    3. Others
  2. Non-specific Endonucleases
    1. DNases
    2. RNases
    3. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Genomics & Genetic Engineering
  2. Drug Discovery & Research
  3. Molecular Biology
  4. Others
3. Market Analysis, Insights and Forecast – By Source
  1. Prokaryotic
  2. Eukaryotic
  3. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical and Biotechnology Companies
  2. Academic & Research Institutes
  3. Others
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Endonucleases Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Specific Endonucleases
    1. Restriction enzymes
    2. CRISPR-Cas nucleases
    3. Others
  2. Non-specific Endonucleases
    1. DNases
    2. RNases
    3. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Genomics & Genetic Engineering
  2. Drug Discovery & Research
  3. Molecular Biology
  4. Others
3. Market Analysis, Insights and Forecast – By Source
  1. Prokaryotic
  2. Eukaryotic
  3. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical and Biotechnology Companies
  2. Academic & Research Institutes
  3. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. U.K.
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Endonucleases Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Specific Endonucleases
    1. Restriction enzymes
    2. CRISPR-Cas nucleases
    3. Others
  2. Non-specific Endonucleases
    1. DNases
    2. RNases
    3. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Genomics & Genetic Engineering
  2. Drug Discovery & Research
  3. Molecular Biology
  4. Others
3. Market Analysis, Insights and Forecast – By Source
  1. Prokaryotic
  2. Eukaryotic
  3. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical and Biotechnology Companies
  2. Academic & Research Institutes
  3. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Endonucleases Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Specific Endonucleases
    1. Restriction enzymes
    2. CRISPR-Cas nucleases
    3. Others
  2. Non-specific Endonucleases
    1. DNases
    2. RNases
    3. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Genomics & Genetic Engineering
  2. Drug Discovery & Research
  3. Molecular Biology
  4. Others
3. Market Analysis, Insights and Forecast – By Source
  1. Prokaryotic
  2. Eukaryotic
  3. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical and Biotechnology Companies
  2. Academic & Research Institutes
  3. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Endonucleases Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Specific Endonucleases
    1. Restriction enzymes
    2. CRISPR-Cas nucleases
    3. Others
  2. Non-specific Endonucleases
    1. DNases
    2. RNases
    3. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Genomics & Genetic Engineering
  2. Drug Discovery & Research
  3. Molecular Biology
  4. Others
3. Market Analysis, Insights and Forecast – By Source
  1. Prokaryotic
  2. Eukaryotic
  3. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical and Biotechnology Companies
  2. Academic & Research Institutes
  3. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
  1. New England Biolabs
  2. Promega Corporation
  3. Thermo Fisher Scientific Inc.
  4. Takara Bio Inc.
  5. QIAGEN
  6. Agilent Technologies Inc.
  7. Merck KGaA
  8. F. Hoffmann-La Roche Ltd

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Technological Advancements in DNA Modification Techniques
2. Technological Advancements in Genetic Engineering
3. New Product Launches, By Key Players
4. Key Industry Developments Such as Mergers, Acquisitions, and Collaborations
5. Overview: Key Start-ups in CRISPR-based Therapeutics
Global Endonucleases Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Specific Endonucleases
    1. Restriction enzymes
    2. CRISPR-Cas nucleases
    3. Others
  2. Non-specific Endonucleases
    1. DNases
    2. RNases
    3. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Genomics & Genetic Engineering
  2. Drug Discovery & Research
  3. Molecular Biology
  4. Others
3. Market Analysis, Insights and Forecast – By Source
  1. Prokaryotic
  2. Eukaryotic
  3. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical and Biotechnology Companies
  2. Academic & Research Institutes
  3. Others
5. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Endonucleases Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Specific Endonucleases
    1. Restriction enzymes
    2. CRISPR-Cas nucleases
    3. Others
  2. Non-specific Endonucleases
    1. DNases
    2. RNases
    3. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Genomics & Genetic Engineering
  2. Drug Discovery & Research
  3. Molecular Biology
  4. Others
3. Market Analysis, Insights and Forecast – By Source
  1. Prokaryotic
  2. Eukaryotic
  3. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical and Biotechnology Companies
  2. Academic & Research Institutes
  3. Others
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Endonucleases Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Specific Endonucleases
    1. Restriction enzymes
    2. CRISPR-Cas nucleases
    3. Others
  2. Non-specific Endonucleases
    1. DNases
    2. RNases
    3. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Genomics & Genetic Engineering
  2. Drug Discovery & Research
  3. Molecular Biology
  4. Others
3. Market Analysis, Insights and Forecast – By Source
  1. Prokaryotic
  2. Eukaryotic
  3. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical and Biotechnology Companies
  2. Academic & Research Institutes
  3. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. U.K.
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Endonucleases Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Specific Endonucleases
    1. Restriction enzymes
    2. CRISPR-Cas nucleases
    3. Others
  2. Non-specific Endonucleases
    1. DNases
    2. RNases
    3. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Genomics & Genetic Engineering
  2. Drug Discovery & Research
  3. Molecular Biology
  4. Others
3. Market Analysis, Insights and Forecast – By Source
  1. Prokaryotic
  2. Eukaryotic
  3. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical and Biotechnology Companies
  2. Academic & Research Institutes
  3. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Endonucleases Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Specific Endonucleases
    1. Restriction enzymes
    2. CRISPR-Cas nucleases
    3. Others
  2. Non-specific Endonucleases
    1. DNases
    2. RNases
    3. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Genomics & Genetic Engineering
  2. Drug Discovery & Research
  3. Molecular Biology
  4. Others
3. Market Analysis, Insights and Forecast – By Source
  1. Prokaryotic
  2. Eukaryotic
  3. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical and Biotechnology Companies
  2. Academic & Research Institutes
  3. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Endonucleases Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Specific Endonucleases
    1. Restriction enzymes
    2. CRISPR-Cas nucleases
    3. Others
  2. Non-specific Endonucleases
    1. DNases
    2. RNases
    3. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Genomics & Genetic Engineering
  2. Drug Discovery & Research
  3. Molecular Biology
  4. Others
3. Market Analysis, Insights and Forecast – By Source
  1. Prokaryotic
  2. Eukaryotic
  3. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical and Biotechnology Companies
  2. Academic & Research Institutes
  3. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
  1. New England Biolabs
  2. Promega Corporation
  3. Thermo Fisher Scientific Inc.
  4. Takara Bio Inc.
  5. QIAGEN
  6. Agilent Technologies Inc.
  7. Merck KGaA
  8. F. Hoffmann-La Roche Ltd

Read Less

List of Figures

Figure 1: Global Endonucleases Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034

Figure 2: Global Endonucleases Market Value Share (%), by Type, 2025 & 2034

Figure 3: Global Endonucleases Market Value Share (%), by Application, 2025 & 2034

Figure 4: Global Endonucleases Market Value Share (%), by Source, 2025 & 2034

Figure 5: Global Endonucleases Market Value Share (%), by End User, 2025 & 2034

Figure 6: Global Endonucleases Market Value (USD million), by Region, 2025 & 2034

Figure 7: North America Endonucleases Market Value (USD million), by Type, 2025 & 2034

Figure 8: North America Endonucleases Market Value Share (%), by Type, 2025

Figure 9: North America Endonucleases Market Value (USD million), by Application, 2025 & 2034

Figure 10: North America Endonucleases Market Value Share (%), by Application, 2025

Figure 11: North America Endonucleases Market Value (USD million), by Source, 2025 & 2034

Figure 12: North America Endonucleases Market Value Share (%), by Source, 2025

Figure 13: North America Endonucleases Market Value (USD million), by End User, 2025 & 2034

Figure 14: North America Endonucleases Market Value Share (%), by End User, 2025

Figure 15: North America Endonucleases Market Value (USD million), By Country, 2025 & 2034

Figure 16: North America Endonucleases Market Value Share (%), By Country, 2025

Figure 17: Europe Endonucleases Market Value (USD million), by Type, 2025 & 2034

Figure 18: Europe Endonucleases Market Value Share (%), by Type, 2025

Figure 19: Europe Endonucleases Market Value (USD million), by Application, 2025 & 2034

Figure 20: Europe Endonucleases Market Value Share (%), by Application, 2025

Figure 21: Europe Endonucleases Market Value (USD million), by Source, 2025 & 2034

Figure 22: Europe Endonucleases Market Value Share (%), by Source, 2025

Figure 23: Europe Endonucleases Market Value (USD million), by End User, 2025 & 2034

Figure 24: Europe Endonucleases Market Value Share (%), by End User, 2025

Figure 25: Europe Endonucleases Market Value (USD million), By Country/ Sub-region, 2025 & 2034

Figure 26: Europe Endonucleases Market Value Share (%), By Country/ Sub-region, 2025

Figure 27: Asia Pacific Endonucleases Market Value (USD million), by Type, 2025 & 2034

Figure 28: Asia Pacific Endonucleases Market Value Share (%), by Type, 2025

Figure 29: Asia Pacific Endonucleases Market Value (USD million), by Application, 2025 & 2034

Figure 30: Asia Pacific Endonucleases Market Value Share (%), by Application, 2025

Figure 31: Asia Pacific Endonucleases Market Value (USD million), by Source, 2025 & 2034

Figure 32: Asia Pacific Endonucleases Market Value Share (%), by Source, 2025

Figure 33: Asia Pacific Endonucleases Market Value (USD million), by End User, 2025 & 2034

Figure 34: Asia Pacific Endonucleases Market Value Share (%), by End User, 2025

Figure 35: Asia Pacific Endonucleases Market Value (USD million), By Country/ Sub-region, 2025 & 2034

Figure 36: Asia Pacific Endonucleases Market Value Share (%), By Country/ Sub-region, 2025

Figure 37: Latin America Endonucleases Market Value (USD million), by Type, 2025 & 2034

Figure 38: Latin America Endonucleases Market Value Share (%), by Type, 2025

Figure 39: Latin America Endonucleases Market Value (USD million), by Application, 2025 & 2034

Figure 40: Latin America Endonucleases Market Value Share (%), by Application, 2025

Figure 41: Latin America Endonucleases Market Value (USD million), by Source, 2025 & 2034

Figure 42: Latin America Endonucleases Market Value Share (%), by Source, 2025

Figure 43: Latin America Endonucleases Market Value (USD million), by End User, 2025 & 2034

Figure 44: Latin America Endonucleases Market Value Share (%), by End User, 2025

Figure 45: Latin America Endonucleases Market Value (USD million), By Country/ Sub-region, 2025 & 2034

Figure 46: Latin America Endonucleases Market Value Share (%), By Country/ Sub-region, 2025

Figure 47: Middle East & Africa Endonucleases Market Value (USD million), by Type, 2025 & 2034

Figure 48: Middle East & Africa Endonucleases Market Value Share (%), by Type, 2025

Figure 49: Middle East & Africa Endonucleases Market Value (USD million), by Application, 2025 & 2034

Figure 50: Middle East & Africa Endonucleases Market Value Share (%), by Application, 2025

Figure 51: Middle East & Africa Endonucleases Market Value (USD million), by Source, 2025 & 2034

Figure 52: Middle East & Africa Endonucleases Market Value Share (%), by Source, 2025

Figure 53: Middle East & Africa Endonucleases Market Value (USD million), by End User, 2025 & 2034

Figure 54: Middle East & Africa Endonucleases Market Value Share (%), by End User, 2025

Figure 55: Middle East & Africa Endonucleases Market Value (USD million), By Country/ Sub-region, 2025 & 2034

Figure 56: Middle East & Africa Endonucleases Market Value Share (%), By Country/ Sub-region, 2025

Figure 57: Global Endonucleases Market Share (%), By Company, 2025

List of Tables

Table 1: Global Endonucleases Market Revenue (USD million) Forecast, by Type, 2021–2034

Table 2: Global Endonucleases Market Revenue (USD million) Forecast, by Specific Endonucleases, 2021–2034

Table 3: Global Endonucleases Market Revenue (USD million) Forecast, by Non-specific Endonucleases, 2021–2034

Table 4: Global Endonucleases Market Revenue (USD million) Forecast, by Application, 2021–2034

Table 5: Global Endonucleases Market Revenue (USD million) Forecast, by Source, 2021–2034

Table 6: Global Endonucleases Market Revenue (USD million) Forecast, by End User, 2021–2034

Table 7: Global Endonucleases Market Revenue (USD million) Forecast, by Region, 2021-2034

Table 8: North America Endonucleases Market Revenue (USD million) Forecast, by Type, 2021-2034

Table 9: North America Endonucleases Market Revenue (USD million) Forecast, by Specific Endonucleases, 2021–2034

Table 10: North America Endonucleases Market Revenue (USD million) Forecast, by Non-specific Endonucleases, 2021–2034

Table 11: North America Endonucleases Market Revenue (USD million) Forecast, by Application, 2021-2034

Table 12: North America Endonucleases Market Revenue (USD million) Forecast, by Source, 2021–2034

Table 13: North America Endonucleases Market Revenue (USD million) Forecast, by End User, 2021-2034

Table 14: North America Endonucleases Market Revenue (USD million) Forecast, By Country, 2021-2034

Table 15: Europe Endonucleases Market Revenue (USD million) Forecast, by Type, 2021-2034

Table 16: Europe Endonucleases Market Revenue (USD million) Forecast, by Specific Endonucleases, 2021–2034

Table 17: Europe Endonucleases Market Revenue (USD million) Forecast, by Non-specific Endonucleases, 2021–2034

Table 18: Europe Endonucleases Market Revenue (USD million) Forecast, by Application, 2021-2034

Table 19: Europe Endonucleases Market Revenue (USD million) Forecast, by Source, 2021–2034

Table 20: Europe Endonucleases Market Revenue (USD million) Forecast, by End User, 2021-2034

Table 21: Europe Endonucleases Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034

Table 22: Asia Pacific Endonucleases Market Revenue (USD million) Forecast, by Type, 2021-2034

Table 23: Asia Pacific Endonucleases Market Revenue (USD million) Forecast, by Specific Endonucleases, 2021–2034

Table 24: Asia Pacific Endonucleases Market Revenue (USD million) Forecast, by Non-specific Endonucleases, 2021–2034

Table 25: Asia Pacific Endonucleases Market Revenue (USD million) Forecast, by Application, 2021-2034

Table 26: Asia Pacific Endonucleases Market Revenue (USD million) Forecast, by Source, 2021–2034

Table 27: Asia Pacific Endonucleases Market Revenue (USD million) Forecast, by End User, 2021-2034

Table 28: Asia Pacific Endonucleases Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034

Table 29: Latin America Endonucleases Market Revenue (USD million) Forecast, by Type, 2021-2034

Table 30: Latin America Endonucleases Market Revenue (USD million) Forecast, by Specific Endonucleases, 2021–2034

Table 31: Latin America Endonucleases Market Revenue (USD million) Forecast, by Non-specific Endonucleases, 2021–2034

Table 32: Latin America Endonucleases Market Revenue (USD million) Forecast, by Application, 2021-2034

Table 33: Latin America Endonucleases Market Revenue (USD million) Forecast, by Source, 2021–2034

Table 34: Latin America Endonucleases Market Revenue (USD million) Forecast, by End User, 2021-2034

Table 35: Latin America Endonucleases Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034

Table 36: Middle East & Africa Endonucleases Market Revenue (USD million) Forecast, by Type, 2021-2034

Table 37: Middle East & Africa Endonucleases Market Revenue (USD million) Forecast, by Specific Endonucleases, 2021–2034

Table 38: Middle East & Africa Endonucleases Market Revenue (USD million) Forecast, by Non-specific Endonucleases, 2021–2034

Table 39: Middle East & Africa Endonucleases Market Revenue (USD million) Forecast, by Application, 2021-2034

Table 40: Middle East & Africa Endonucleases Market Revenue (USD million) Forecast, by Source, 2021–2034

Table 41: Middle East & Africa Endonucleases Market Revenue (USD million) Forecast, by End User, 2021-2034

Table 42: Middle East & Africa Endonucleases Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 167

Buy Now

Download Free Sample

Security Code

Get 30-60 hrs Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

(APAC) +91 744 740 1245
sales@fortunebusinessinsights.com